RA Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-734,343
| Closed | -$60.4M | – | 106 |
|
|
2022
Q1 | $60.4M | Buy |
734,343
+353,297
| +93% | +$29M | 1.32% | 21 |
|
|
2021
Q4 | $55.9M | Buy |
+381,046
| New | +$55.9M | 0.99% | 28 |
|
|
2014
Q2 | – | Sell |
-656,767
| Closed | -$12.5M | – | 32 |
|
|
2014
Q1 | $12.5M | Hold |
656,767
| – | – | 0.9% | 20 |
|
|
2013
Q4 | $10.9M | Buy |
656,767
+105,044
| +19% | +$1.75M | 1.27% | 17 |
|
|
2013
Q3 | $8.36M | Buy |
+551,723
| New | +$8.36M | 0.87% | 22 |
|